Liraglutide Therapy in Obese Patients Alters Macrophage Phenotype and Decreases Their Tumor Necrosis Factor Alpha Release and Oxidative Stress Markers-A Pilot Study.

Autor: Bułdak Ł; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Medyków 18, 40-752 Katowice, Poland., Bołdys A; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Medyków 18, 40-752 Katowice, Poland., Skudrzyk E; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Medyków 18, 40-752 Katowice, Poland., Machnik G; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Medyków 18, 40-752 Katowice, Poland., Okopień B; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Medyków 18, 40-752 Katowice, Poland.

Publikováno v: Metabolites [Metabolites] 2024 Oct 16; Vol. 14 (10). Date of Electronic Publication: 2024 Oct 16.

The impact of wound-healing assay, phorbol myristate acetate (PMA) stimulation and siRNA-mediated FURIN gene silencing on endogenous retroviral ERVW-1 expression level in U87-MG astrocytoma cells.

Autor: Machnik G; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland. Electronic address: gmachnik@sum.edu.pl., Bułdak Ł; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland., Zapletal-Pudełko K; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland., Grabarek BO; Collegium Medicum, WSB University, Dabrowa Gornicza, Poland; Department of Molecular Biology, Gyncentrum Fertility Clinic, Katowice, Poland., Staszkiewicz R; Collegium Medicum, WSB University, Dabrowa Gornicza, Poland; Department of Neurosurgery, 5th Military Clinical Hospital with the SP ZOZ Polyclinic in Krakow, Krakow, Poland; Department of Neurosurgery, Faculty of Medicine, Academy of Silesia, Katowice, Poland., Sobański D; Collegium Medicum, WSB University, Dabrowa Gornicza, Poland; Department of Neurosurgery, Szpital sw. Rafala in Cracow, Poland., Okopień B; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.

Publikováno v: Advances in medical sciences [Adv Med Sci] 2024 Mar; Vol. 69 (1), pp. 113-124. Date of Electronic Publication: 2024 Feb 23.

The Application of Peptide Nucleic Acids (PNA) in the Inhibition of Proprotein Convertase Subtilisin/Kexin 9 ( PCSK9 ) Gene Expression in a Cell-Free Transcription/Translation System.

Autor: Polak A; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Science in Katowice, Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland., Machnik G; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Science in Katowice, Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland., Bułdak Ł; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Science in Katowice, Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland., Ruczyński J; Laboratory of Chemistry of Biologically Active Compounds, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland., Prochera K; Laboratory of Chemistry of Biologically Active Compounds, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland., Bujak O; Laboratory of Chemistry of Biologically Active Compounds, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland., Mucha P; Laboratory of Chemistry of Biologically Active Compounds, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland., Rekowski P; Laboratory of Chemistry of Biologically Active Compounds, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland., Okopień B; Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Science in Katowice, Medical University of Silesia, Medykow 18, 40-752 Katowice, Poland.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 25; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 25.

The impact of glucagon and exenatide on oxidative stress levels and antioxidative enzyme expression in in vitro induced steatosis in HepG2 cell culture.

Autor: Bołdys A; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland., Bułdak Ł; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland. lbuldak@sum.edu.pl., Skudrzyk E; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland., Machnik G; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland., Okopień B; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.

Publikováno v: Endokrynologia Polska [Endokrynol Pol] 2024; Vol. 75 (4), pp. 419-427.

Initial clinical, laboratory and radiological features of SARS-CoV-2-infected patients and their impact on the course of the disease.

Autor: Maligłówka M; Department of Internal Medicine and Clinical Pharmacology, School of Medicine, Medical University of Silesia, Katowice, Poland., Bułdak Ł; Department of Internal Medicine and Clinical Pharmacology, School of Medicine, Medical University of Silesia, Katowice, Poland., Cyrnek M; Department of Internal Medicine and Clinical Pharmacology, School of Medicine, Medical University of Silesia, Katowice, Poland., Hachuła M; Department of Internal Medicine and Clinical Pharmacology, School of Medicine, Medical University of Silesia, Katowice, Poland., Kosowski M; Department of Internal Medicine and Clinical Pharmacology, School of Medicine, Medical University of Silesia, Katowice, Poland., Basiak M; Department of Internal Medicine and Clinical Pharmacology, School of Medicine, Medical University of Silesia, Katowice, Poland., Szkróbka W; Department of Internal Medicine and Clinical Pharmacology, School of Medicine, Medical University of Silesia, Katowice, Poland., Bosowska J; Department of Radiodiagnostics, Invasive Radiology and Nuclear Medicine, Department of Radiology and Nuclear Medicine, School of Medicine, Medical University of Silesia, Katowice, Poland., Cebula M; Department of Radiodiagnostics, Invasive Radiology and Nuclear Medicine, Department of Radiology and Nuclear Medicine, School of Medicine, Medical University of Silesia, Katowice, Poland., Holecki M; Department of Internal Medicine, Autoimmune and Metabolic Diseases, School of Medicine, Medical University of Silesia, Katowice, Poland., Okopień B; Department of Internal Medicine and Clinical Pharmacology, School of Medicine, Medical University of Silesia, Katowice, Poland.

Publikováno v: Advances in clinical and experimental medicine : official organ Wroclaw Medical University [Adv Clin Exp Med] 2023 Oct; Vol. 32 (10), pp. 1125-1132.